Antidepressants and traffic safety

Drugs, Driving and Traffic Safety

Volumn , Issue , 2009, Pages 307-313

  Verster, Joris C ^a   Ramaekers, Johannes G ^b  

^a UTRECHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79961154132     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-7643-9923-8_18     Document Type: Chapter

References (15)

1. Louwerens JW, Brookhuis KA, O'Hanlon JF (1984) The effects of antidepressants oxaprotiline, mianserin, amitriptyline and doxepin upon actual driving performance. Groningen, The Netherlands. Traffic research Center, technical report.
2. Schoenmakers EAJM, Robbe HWJ, O'Hanlon JF (1989) Acute and subchronic effects of the antidepressants levoprotiline and doxepin on the performance of healthy volunteers in psychometric and actual driving tests. Maastricht, The Netherlands. University of Maastricht, Institute for Human Psychopharmacology, technical report.
3. Ramaekers JG, Van Veggel LM, O'Hanlon JF (1994) A cross-study comparison of the effects of moclobemide and brofaromide on actual driving performance and estimated sleep. Clin Neuropsychopharmacol 17(suppl 1):S9-S18.
4. Robbe HW, O'Hanlon JF (1995) Acute and subchronic effects of paroxetine 20 and 40 mon actual driving, psychomotor performance and subjective assessments in healthy volunteers. Eur Neuropsychopharmacol 5:35-42.
5. Van Laar MW, Van Willigenburg AP, Volkerts ER (1995) Acute and subchronic effects of nefazodone and imipramine on highway driving, cognitive functions, and daytime sleepiness in healthy adult and elderly subjects. J Clin Psychopharmacol 15:30-40.
6. Ramaekers JG, Swijgman HF, O'Hanlon JF (1992) Effects of moclobemide and mianserin on highway driving, psychometric performance and subjective parameters, relative to placebo. Psychopharmacology 106(suppl):S62-S67.
7. O'Hanlon JF, Robbe HW, Vermeeren A et al. (1998) Venlafaxine's effects on healthy volunteers' driving, psychomotor, and vigilance performance during 15-day fixed and incremental dosing regimens. J Clin Psychopharmacol 18:212-221.
8. Ramaekers JG, Muntjewerff ND, O'Hanlon JF (1995) A comparative study of acute and subchronic effects of dothiepin, fluoxetine and placebo on psychomotor and actual driving performance. Br J Clin Pharmacol 39:397-404.
9. Ramaekers JG, Muntjewerff ND, Van Veggel LMA et al. (1998) Effects of nocturnal doses of mirtazapine and mianserin on sleep and on daytime psychomotor and driving performance in young, healthy volunteers. Hum Psychopharmacol Clin Exp 13(suppl 2):S7-S97.
10. Wingen M, Bothmer J, Langer S, Ramaekers JG (2005) Actual driving performance and psychomotor function in healthy subjects after acute and subchronic treatment with escitalopram, mirtazapine, and placebo: a crossover trial. J Clin Psychiatry 66:436-443.
11. Ramaekers JG. Antidepressants and driver impairment: empirical evidence from a standard on-the-road test. J Clin Psychiatry 2003, 64:20-29.
12. Wingen M, ramaekers JG, Schmitt A J (2006) Driving impairment in depressed patients receiving long-term antidepressant treatment. Psychopharmacology 188:84-91.
13. Leveille SG, Buchner DM, Koepsell TD, McCloskey LW, Wolf ME, Wagner EH (1994) Psychoactive medications and injurious motor vehicle collisions involving older drivers. Epidemiology 5:591-598
14. Ray WA, Fought RL, Decker MD (1992) Psychoactive drugs and the risk of injurious motor vehicle crashes in elderly drivers. Am J Epidemiol 136:873-883
15. Barbone F, McMahon AD, Davey PG, Morris AD, Reid IC, McDevitt DG, MacDonald TM (1998) Association of road-traffic accidents with benzodiazepine use. Lancet 352:1331-1336